Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?

MLA

Ladikou, Eleni E., et al. “Von Willebrand Factor (VWF): Marker of Endothelial Damage and Thrombotic Risk in COVID-19?” Clinical Medicine (London, England), vol. 20, no. 5, Sept. 2020, pp. e178–82. EBSCOhost, https://doi.org/10.7861/clinmed.2020-0346.

APA

Ladikou, E. E., Sivaloganathan, H., Milne, K. M., Arter, W. E., Ramasamy, R., Saad, R., Stoneham, S. M., Philips, B., Eziefula, A. C., & Chevassut, T. (2020). Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19? Clinical Medicine (London, England), 20(5), e178–e182. https://doi.org/10.7861/clinmed.2020-0346

Chicago

Ladikou, Eleni E, Helena Sivaloganathan, Kate M Milne, William E Arter, Roshan Ramasamy, Ramy Saad, Simon M Stoneham, Barbara Philips, Alice C Eziefula, and Timothy Chevassut. 2020. “Von Willebrand Factor (VWF): Marker of Endothelial Damage and Thrombotic Risk in COVID-19?” Clinical Medicine (London, England) 20 (5): e178–82. doi:10.7861/clinmed.2020-0346.